Genflow Biosciences plc

GENF.L · LSE
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
12/31/2023
Operating Activities
Net Income-£369-£369-£531-£1,007
Dep. & Amort.£0£0£0£1
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0-£1£0
Change in WC-£41-£41£48£222
Other Non-Cash-£9-£9£43-£37
Operating Cash Flow-£418-£418-£442-£811
Investing Activities
PP&E Inv.£0£0£0£2
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0£0£0£0
Investing Cash Flow£0£0£0£2
Financing Activities
Debt Repay.£0£0£0
Stock Issued£0£0£0£0
Stock Repurch.£0£0-£29£0
Dividends Paid£0£0£0£0
Other Fin. Act.£434£434£26£0
Financing Cash Flow£434£434-£3£0
Forex Effect-£16-£16£14£0
Net Chg. in Cash£0£0£0-£823
Supplemental Information
Beg. Cash£0£0£0£1,507
End Cash£0£0£0£684
Free Cash Flow-£418-£418-£441-£809